Computer chip manufacturers are responding to pandemic-driven supply chain hurdles—as well as to state government incentives and federal funding allocated by the CHIPS and Science Act signed by President Biden in August—with projects to build plants and boost their U.S.-based production.
The first large-scale prefabricated and multimodular Current Good Manufacturing Practices (cGMP) manufacturing facility built in the nation also helps the National Cancer Institute produce an experimental therapy.